Cumulative dermatologic toxicity with ipilimumab and vemurafenib responsive to corticosteroids.

Abstract excerpt

Dermatologic toxicity is a known reaction of ipilimumab and vemurafenib. Because of the lack of effective treatments and aggressive nature of melanoma, treatments are often discontinued and new treatments are initiated in rapid succession. We report what we believe to be the first case of cumulative dermatologic toxicity secondary to rapid-sequential treatment with ipilimumab and vemurafenib for metastatic...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Exanthema
• Share to Adrenal Cortex Hormones
• Share to Drug Administration Schedule